Hauptkonkurrenten
Dividendenrendite (Y) Dividendenrendite (Y+1) KGV (Y) Price to Book (Y) EV / Sales (Y) Marktkap. / EBITDA (Y) Marktkap. / EBIT (Y) Kap.($)
- - - - - - - 11,09 Mio.
0,58 %0,65 %34.57x21.09x12.36x25.86x26.91x 1.037 Mrd.
2,1 %2,2 %27.4x6.96x6.26x17.33x18.83x 615 Mrd.
2,71 %2,85 %33x12608.26x7.49x15.4x15.88x 448 Mrd.
3,01 %3,08 %17.76x6.57x4.4x10.85x12.2x 326 Mrd.
2,84 %2,99 %21.11x6.17x5.63x13.79x14.87x 293 Mrd.
1,97 %2,07 %21.21x4.97x4.47x12.37x13.38x 264 Mrd.
3,55 %3,46 %14.09x6.22x5.24x10.8x12.71x 216 Mrd.
2,76 %2,91 %24.01x18.47x6.34x11.18x14.51x 198 Mrd.
2,53 %2,62 %-46.95x8.23x5.62x31.09x62.21x 162 Mrd.
6,95 %7,03 %12.61x1.61x3.09x7.81x8.83x 141 Mrd.
4,15 %4,23 %11.8x5.33x3.23x8.69x9.34x 124 Mrd.
-.--%-.--%26.94x5.41x8.14x18.34x19.22x 120 Mrd.
5,54 %5,86 %11.59x1.23x2.17x6.97x7.93x 105 Mrd.
3,64 %3,83 %12.04x4.4x2.71x7.84x8.96x 102 Mrd.
1,87 %2,15 %23.62x5.35x8x15.12x15.83x 73,72 Mrd.
3,68 %3,76 %44.68x1.19x2.75x9.73x27.83x 54,35 Mrd.
0,48 %0,54 %39.86x5.34x8.99x29.71x30.83x 53,93 Mrd.
0,49 %1,34 %20.3x1.65x1.71x8.12x13.63x 52,66 Mrd.
Durchschnitt 2,71 % 2,87 % 19,42x 706,58x 5,48x 14,50x 18,55x 230,78 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung 2,28 % 2,39 % 23,16x 1.296,13x 7,12x 16,96x 19,54x
Pharmazeutika - Andere